Director Summers Andrew sold $1,976,606 worth of shares (65,630 units at $30.12) (SEC Form 4)
$ELMD
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Electromed, Inc. [ ELMD ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 12/02/2024 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 12/02/2024 | S | 8,370 | D | $29.966(1) | 343,551 | I | By Summers Value Fund LP(2) | ||
| Common Stock | 12/02/2024 | S | 362 | D | $30.795 | 343,189 | I | By Summers Value Fund LP(2) | ||
| Common Stock | 12/02/2024 | S | 8,731 | D | $30.183(3) | 189,838 | I | By SVP Deal Fund I LP(4) | ||
| Common Stock | 12/03/2024 | S | 17,718 | D | $30.209(5) | 325,471 | I | By Summers Value Fund LP(2) | ||
| Common Stock | 12/03/2024 | S | 17,718 | D | $30.151(6) | 172,120 | I | By SVP Deal Fund I LP(4) | ||
| Common Stock | 12/04/2024 | S | 6,366 | D | $30.096(7) | 319,105 | I | By Summers Value Fund LP(2) | ||
| Common Stock | 12/04/2024 | S | 6,365 | D | $29.861(8) | 165,755 | I | By SVP Deal Fund I LP(4) | ||
| Common Stock | 9,000 | D | ||||||||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Explanation of Responses: |
| 1. Reflects the weighted average price of 8,370 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on December 2, 2024 with sale prices ranging from $29.620 to $30.555 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2. Securities owned directly by Summers Value Fund LP ("Summers Value Fund"). Mr. Summers, as the Managing Member of each of Summers Value Partners GP LLC, the general partner of Summers ValueFund, and Summers Value Partners LLC ("Summers Value Partners"), the investment manager of Summers Value Fund, may be deemed to beneficially own the securities owned directly by Summers ValueFund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
| 3. Reflects the weighted average price of 8,731 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on December 2, 2024 with sale prices ranging from $30.000 to $30.335 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4. Securities owned directly by SVP Deal Fund 1 LP ("SVP Fund"). Mr. Summers, as the Managing Member of each of SVP Deal Fund 1 GP LLC, the general partner of SVP Fund, and Summers Value Partners, the investment manager of SVP Fund, may be deemed to beneficially own the securities owned directly by SVP Fund. Mr. Summers expressly disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
| 5. Reflects the weighted average price of 17,718 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on December 3, 2024 with sale prices ranging from $30.015 to $30.465 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6. Reflects the weighted average price of 17,718 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on December 3, 2024 with sale prices ranging from $30.110 to $30.260 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7. Reflects the weighted average price of 6,366 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on December 4, 2024 with sale prices ranging from $29.935 to $30.210 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 8. Reflects the weighted average price of 6,365 shares of common stock of Electromed, Inc. sold by the reporting person in multiple transactions on December 4, 2024 with sale prices ranging from $29.800 to $29.990 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| /s/ Joshua L. Colburn, Attorney-in-fact | 12/04/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||